Royce & Associates LP trimmed its position in Siga Technologies Inc. (NASDAQ:SIGA – Free Report) by 91.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 46,282 shares of the company’s stock after selling 504,728 shares during the quarter. Royce & Associates LP owned 0.06% of Siga Technologies worth $157,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Bank of New York Mellon Corp increased its stake in shares of Siga Technologies by 1.0% during the first quarter. Bank of New York Mellon Corp now owns 256,803 shares of the company’s stock valued at $1,374,000 after buying an additional 2,635 shares during the period. Hsbc Holdings PLC lifted its stake in Siga Technologies by 26.3% in the second quarter. Hsbc Holdings PLC now owns 16,904 shares of the company’s stock worth $62,000 after acquiring an additional 3,519 shares during the period. First Trust Advisors LP lifted its stake in Siga Technologies by 3.5% in the first quarter. First Trust Advisors LP now owns 160,355 shares of the company’s stock worth $858,000 after acquiring an additional 5,411 shares during the period. State of Alaska Department of Revenue boosted its holdings in Siga Technologies by 34.6% in the third quarter. State of Alaska Department of Revenue now owns 24,251 shares of the company’s stock valued at $82,000 after acquiring an additional 6,233 shares in the last quarter. Finally, Seven Mile Advisory purchased a new position in Siga Technologies during the 3rd quarter valued at $34,000. Institutional investors own 55.40% of the company’s stock.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Siga Technologies in a research report on Wednesday, November 4th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, Siga Technologies has an average rating of “Sell”.
View Our Latest Research Report on Siga Technologies
Siga Technologies Stock Performance
Shares of SIGA opened at $2.40 on Friday. The firm’s 50-day simple moving average is $3.13 and its two-hundred day simple moving average is $4.12. Siga Technologies Inc. has a fifty-two week low of $2.30 and a fifty-two week high of $7.11.
Siga Technologies (NASDAQ:SIGA – Get Free Report) last issued its quarterly earnings results on Monday, November 9th. The company reported ($0.04) EPS for the quarter. Siga Technologies had a return on equity of 0.40% and a net margin of 1.31%. The company had revenue of $1.32 million during the quarter.
Siga Technologies Profile
SIGA Technologies is a commercial-stage pharmaceutical company focused on developing and supplying treatments for serious infectious diseases. Its principal product is TPOXX (tecovirimat), an antiviral medicine approved in the United States to treat smallpox in adults and children. TPOXX is available in oral and intravenous formulations. SIGA supplies the medicine primarily to government agencies for emergency preparedness and response, including stockpiles intended to address potential smallpox outbreaks.
Read More
- Five stocks we like better than Siga Technologies
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Siga Technologies Inc. (NASDAQ:SIGA – Free Report).
Receive News & Ratings for Siga Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siga Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
